Ruikang Tao

Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer.

Yuping Yin, Qian Shen, Peng Zhang et al. · PubMed · 2017 · 56 citations · Full text

Combination of <scp>PARP</scp> inhibitor and <scp>CDK4</scp>/6 inhibitor modulates <scp>cGAS</scp>/<scp>STING‐</scp>dependent therapy‐induced senescence and provides “one‐two punch” opportunity with <scp>anti‐PD‐L1</scp> therapy in colorectal cancer

Tao Wang, Weizhen Liu, Qian Shen et al. · Cancer Science · 2023 · 35 citations · Full text

Parp Inhibitor, Immunology, Cell Death +19

Wee1 inhibition can suppress tumor proliferation and sensitize p53 mutant colonic cancer cells to the anticancer effect of irinotecan

Yunping Yin, Qian Shen, Ruikang Tao et al. · Molecular Medicine Reports · 2017 · 30 citations · Full text

Chemoprevention Strategy, Pathology, Anticancer Effect +16

Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer

Xianxiong Ma, Ruikang Tao, Lei Li et al. · Oncology Reports · 2018 · 26 citations · Full text

The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer

Yuping Yin, Weizhen Liu, Qian Shen et al. · Molecular Cancer Therapeutics · 2019 · 22 citations · Full text